Thomas M. Shannon is president and CEO of the BrightStar Wisconsin Foundation, Inc. As co-founder, he donates his time as head of operations of this charitable organization whose mission it is to create high-growth jobs through early-stage investment. He also has served as board chairman as well as a lead investor in the start-up funding of Shamrock Energy Corporation, Neenah, WI; Proxim Diagnostics, Sunnyvale, CA; Somna Therapeutics LLC, Milwaukee; and Aver Informatics of Green Bay, WI.
He was most recently biotech company Prodesse’s CEO and exited the firm after its sale to Gen-Probe, Inc., in November of 2009 for a purchase price of $72 million. In 1996, he founded Shamrock Partners which led the investment group in Prodesse's initial funding in 2002 as well as the purchase in 1997 of three regional transportation companies in Nebraska and Florida, selling his majority interest in those companies in 2001.
Prior to that, Mr. Shannon held a variety of senior level management positions in sales and general management as a registered principal for Equitable and its subsidiaries, including Alliance Capital and Donaldson, Lufkin and Jenrette.
Other boards and committees he has been appointed to include The Wisconsin Angel Network, Promentis Pharmaceuticals, Stemina Biomarker Discovery, OKANJO Partners, Inc., The Nebraska Special Olympics and BizStarts Milwaukee. He holds a finance degree from the University of Wisconsin and earned the Certified Financial Planner (CFP) and Chartered Financial Consultant (CHFC) credentials.